Molecular Diagnostics-EMEA Market Status and Trend Report 2013-2023
Report Summary
Molecular Diagnostics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Molecular Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Molecular Diagnostics in EMEA, with company and product introduction, position in the Molecular Diagnostics market
Market status and development trend of Molecular Diagnostics by types and applications
Cost and profit status of Molecular Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the EMEA Molecular Diagnostics market as:
EMEA Molecular Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Molecular Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Infectious Disease
Oncology
Genetics
Microbiology
EMEA Molecular Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Laboratories
EMEA Molecular Diagnostics Market: Players Segment Analysis (Company and Product introduction, Molecular Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Roche Diagnostics
QIAGEN N.V.
Hologic Inc
Grifols
Abbott Laboratories
Siemens Healthcare
Becton, Dickinson
Beckman Coulter
bioM?rieux SA
Cepheid
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Molecular Diagnostics-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Molecular Diagnostics industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Molecular Diagnostics 2013-2017, and development forecast 2018-2023
Main market players of Molecular Diagnostics in EMEA, with company and product introduction, position in the Molecular Diagnostics market
Market status and development trend of Molecular Diagnostics by types and applications
Cost and profit status of Molecular Diagnostics, and marketing status
Market growth drivers and challenges
The report segments the EMEA Molecular Diagnostics market as:
EMEA Molecular Diagnostics Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Molecular Diagnostics Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Infectious Disease
Oncology
Genetics
Microbiology
EMEA Molecular Diagnostics Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Laboratories
EMEA Molecular Diagnostics Market: Players Segment Analysis (Company and Product introduction, Molecular Diagnostics Sales Volume, Revenue, Price and Gross Margin):
Roche Diagnostics
QIAGEN N.V.
Hologic Inc
Grifols
Abbott Laboratories
Siemens Healthcare
Becton, Dickinson
Beckman Coulter
bioM?rieux SA
Cepheid
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF MOLECULAR DIAGNOSTICS
1.1 Definition of Molecular Diagnostics in This Report
1.2 Commercial Types of Molecular Diagnostics
1.2.1 Infectious Disease
1.2.2 Oncology
1.2.3 Genetics
1.2.4 Microbiology
1.3 Downstream Application of Molecular Diagnostics
1.3.1 Hospital
1.3.2 Laboratories
1.4 Development History of Molecular Diagnostics
1.5 Market Status and Trend of Molecular Diagnostics 2013-2023
1.5.1 EMEA Molecular Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Molecular Diagnostics in EMEA 2013-2017
2.2 Consumption Market of Molecular Diagnostics in EMEA by Regions
2.2.1 Consumption Volume of Molecular Diagnostics in EMEA by Regions
2.2.2 Revenue of Molecular Diagnostics in EMEA by Regions
2.3 Market Analysis of Molecular Diagnostics in EMEA by Regions
2.3.1 Market Analysis of Molecular Diagnostics in Europe 2013-2017
2.3.2 Market Analysis of Molecular Diagnostics in Middle East 2013-2017
2.3.3 Market Analysis of Molecular Diagnostics in Africa 2013-2017
2.4 Market Development Forecast of Molecular Diagnostics in EMEA 2018-2023
2.4.1 Market Development Forecast of Molecular Diagnostics in EMEA 2018-2023
2.4.2 Market Development Forecast of Molecular Diagnostics by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Molecular Diagnostics in EMEA by Types
3.1.2 Revenue of Molecular Diagnostics in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Molecular Diagnostics in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Molecular Diagnostics in EMEA by Downstream Industry
4.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Diagnostics by Downstream Industry in Europe
4.2.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Middle East
4.2.3 Demand Volume of Molecular Diagnostics by Downstream Industry in Africa
4.3 Market Forecast of Molecular Diagnostics in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR DIAGNOSTICS
5.1 EMEA Economy Situation and Trend Overview
5.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 MOLECULAR DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Molecular Diagnostics in EMEA by Major Players
6.2 Revenue of Molecular Diagnostics in EMEA by Major Players
6.3 Basic Information of Molecular Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Players
6.3.2 Employees and Revenue Level of Molecular Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MOLECULAR DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche Diagnostics
7.1.1 Company profile
7.1.2 Representative Molecular Diagnostics Product
7.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.2 QIAGEN N.V.
7.2.1 Company profile
7.2.2 Representative Molecular Diagnostics Product
7.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN N.V.
7.3 Hologic Inc
7.3.1 Company profile
7.3.2 Representative Molecular Diagnostics Product
7.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc
7.4 Grifols
7.4.1 Company profile
7.4.2 Representative Molecular Diagnostics Product
7.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Grifols
7.5 Abbott Laboratories
7.5.1 Company profile
7.5.2 Representative Molecular Diagnostics Product
7.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.6 Siemens Healthcare
7.6.1 Company profile
7.6.2 Representative Molecular Diagnostics Product
7.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.7 Becton, Dickinson
7.7.1 Company profile
7.7.2 Representative Molecular Diagnostics Product
7.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson
7.8 Beckman Coulter
7.8.1 Company profile
7.8.2 Representative Molecular Diagnostics Product
7.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter
7.9 bioM?rieux SA
7.9.1 Company profile
7.9.2 Representative Molecular Diagnostics Product
7.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of bioM?rieux SA
7.10 Cepheid
7.10.1 Company profile
7.10.2 Representative Molecular Diagnostics Product
7.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR DIAGNOSTICS
8.1 Industry Chain of Molecular Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR DIAGNOSTICS
9.1 Cost Structure Analysis of Molecular Diagnostics
9.2 Raw Materials Cost Analysis of Molecular Diagnostics
9.3 Labor Cost Analysis of Molecular Diagnostics
9.4 Manufacturing Expenses Analysis of Molecular Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF MOLECULAR DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Molecular Diagnostics in This Report
1.2 Commercial Types of Molecular Diagnostics
1.2.1 Infectious Disease
1.2.2 Oncology
1.2.3 Genetics
1.2.4 Microbiology
1.3 Downstream Application of Molecular Diagnostics
1.3.1 Hospital
1.3.2 Laboratories
1.4 Development History of Molecular Diagnostics
1.5 Market Status and Trend of Molecular Diagnostics 2013-2023
1.5.1 EMEA Molecular Diagnostics Market Status and Trend 2013-2023
1.5.2 Regional Molecular Diagnostics Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Molecular Diagnostics in EMEA 2013-2017
2.2 Consumption Market of Molecular Diagnostics in EMEA by Regions
2.2.1 Consumption Volume of Molecular Diagnostics in EMEA by Regions
2.2.2 Revenue of Molecular Diagnostics in EMEA by Regions
2.3 Market Analysis of Molecular Diagnostics in EMEA by Regions
2.3.1 Market Analysis of Molecular Diagnostics in Europe 2013-2017
2.3.2 Market Analysis of Molecular Diagnostics in Middle East 2013-2017
2.3.3 Market Analysis of Molecular Diagnostics in Africa 2013-2017
2.4 Market Development Forecast of Molecular Diagnostics in EMEA 2018-2023
2.4.1 Market Development Forecast of Molecular Diagnostics in EMEA 2018-2023
2.4.2 Market Development Forecast of Molecular Diagnostics by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Molecular Diagnostics in EMEA by Types
3.1.2 Revenue of Molecular Diagnostics in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Molecular Diagnostics in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Molecular Diagnostics in EMEA by Downstream Industry
4.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Major Countries
4.2.1 Demand Volume of Molecular Diagnostics by Downstream Industry in Europe
4.2.2 Demand Volume of Molecular Diagnostics by Downstream Industry in Middle East
4.2.3 Demand Volume of Molecular Diagnostics by Downstream Industry in Africa
4.3 Market Forecast of Molecular Diagnostics in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF MOLECULAR DIAGNOSTICS
5.1 EMEA Economy Situation and Trend Overview
5.2 Molecular Diagnostics Downstream Industry Situation and Trend Overview
CHAPTER 6 MOLECULAR DIAGNOSTICS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Molecular Diagnostics in EMEA by Major Players
6.2 Revenue of Molecular Diagnostics in EMEA by Major Players
6.3 Basic Information of Molecular Diagnostics by Major Players
6.3.1 Headquarters Location and Established Time of Molecular Diagnostics Major Players
6.3.2 Employees and Revenue Level of Molecular Diagnostics Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 MOLECULAR DIAGNOSTICS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Roche Diagnostics
7.1.1 Company profile
7.1.2 Representative Molecular Diagnostics Product
7.1.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Roche Diagnostics
7.2 QIAGEN N.V.
7.2.1 Company profile
7.2.2 Representative Molecular Diagnostics Product
7.2.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of QIAGEN N.V.
7.3 Hologic Inc
7.3.1 Company profile
7.3.2 Representative Molecular Diagnostics Product
7.3.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Hologic Inc
7.4 Grifols
7.4.1 Company profile
7.4.2 Representative Molecular Diagnostics Product
7.4.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Grifols
7.5 Abbott Laboratories
7.5.1 Company profile
7.5.2 Representative Molecular Diagnostics Product
7.5.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.6 Siemens Healthcare
7.6.1 Company profile
7.6.2 Representative Molecular Diagnostics Product
7.6.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Siemens Healthcare
7.7 Becton, Dickinson
7.7.1 Company profile
7.7.2 Representative Molecular Diagnostics Product
7.7.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Becton, Dickinson
7.8 Beckman Coulter
7.8.1 Company profile
7.8.2 Representative Molecular Diagnostics Product
7.8.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Beckman Coulter
7.9 bioM?rieux SA
7.9.1 Company profile
7.9.2 Representative Molecular Diagnostics Product
7.9.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of bioM?rieux SA
7.10 Cepheid
7.10.1 Company profile
7.10.2 Representative Molecular Diagnostics Product
7.10.3 Molecular Diagnostics Sales, Revenue, Price and Gross Margin of Cepheid
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF MOLECULAR DIAGNOSTICS
8.1 Industry Chain of Molecular Diagnostics
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF MOLECULAR DIAGNOSTICS
9.1 Cost Structure Analysis of Molecular Diagnostics
9.2 Raw Materials Cost Analysis of Molecular Diagnostics
9.3 Labor Cost Analysis of Molecular Diagnostics
9.4 Manufacturing Expenses Analysis of Molecular Diagnostics
CHAPTER 10 MARKETING STATUS ANALYSIS OF MOLECULAR DIAGNOSTICS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
